Friday, June 26, 2026

HomeHealth NewsBladder cancer treatment reprograms bone marrow to boost immune system's cancer-fighting ability

Bladder cancer treatment reprograms bone marrow to boost immune system’s cancer-fighting ability

- Advertisement -

Graphical abstract. Credit: Cancer Cell (2025). DOI: 10.1016/j.ccell.2025.05.002

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed